Since the enactment of the Biologics Price Competition and Innovation Act (BPCIA), the Federal Drug Administration (FDA) has approved more than 20 biosimilar products, and, as the market has grown, litigation activity concerning biosimilars has increased rapidly. Signed into law as part of the Affordable Care Act on March 23, 2010, the BPCIA is codified …
Filtered by tag:
ACA
Mitchell & Mitchell on Health Care and the Trump Agenda, Part 19: Continuing Impact of 2017 “Repeal and Replace” Efforts
This is Part 19 in an ongoing series regarding changes in health care that may take place—and actual changes that do take place—with the Trump administration. The likely implementation issues to be encountered for both potential and actual changes are described, based on detailed methods of analysis. The emphasis is on what these shifts mean …
Mitchell & Mitchell on Health Care and the Trump Agenda, Part 18: Redirecting Group Reactions To the State Level
This is Part 18 in an ongoing series regarding changes in health care that may take place—and actual changes that do take place—with the Trump administration. The likely implementation issues to be encountered for both potential and actual changes are described, based on detailed methods of analysis. The emphasis is on what these shifts mean …
Mitchell & Mitchell on Health Care and the Trump Agenda, Part 17: Groups and Organizations Drive Program Decisions
This is Part 17 in an ongoing series regarding changes in health care that may take place—and actual changes that do take place—with the Trump administration. The likely implementation issues to be encountered for both potential and actual changes are described, based on detailed methods of analysis. The emphasis is on what these shifts mean …
Mitchell & Mitchell on Health Care and the Trump Agenda, Part 16: No One is in Charge of Health Care
This is part 16 in an ongoing series regarding changes in health care that may take place—and actual changes that do take place—with the Trump administration. The likely implementation issues to be encountered for both potential and actual changes are described, based on detailed methods of analysis. The emphasis is on what these shifts mean …
Mitchell & Mitchell on Health Care and the Trump Agenda, Part 15: Design Failure for Medicaid Program Reform
This is Part 15 in an ongoing series regarding changes in health care that may take place—and actual changes that do take place—with the Trump administration. The likely implementation issues to be encountered for both potential and actual changes are described, based on detailed methods of analysis. The emphasis is on what these shifts mean …
Mitchell & Mitchell on Health Care and the Trump Agenda, Part 14: CBO Analysis Distorts Debates
This is Part 14 in an ongoing series regarding changes in health care that may take place—and actual changes that do take place—with the Trump administration. The likely implementation issues to be encountered for both potential and actual changes are described, based on detailed methods of analysis. The emphasis is on what these shifts mean …
Mitchell & Mitchell on Health Care and the Trump Agenda, Part 13: An Opportunity for Attorneys to Help Shape Health Care Policy?
This is Part 13 in an ongoing series regarding changes in health care that may take place—and actual changes that do take place—with the Trump administration. The likely implementation issues to be encountered for both potential and actual changes are described, based on detailed methods of analysis. The emphasis is on what these shifts mean …
Mitchell & Mitchell on Health Care and the Trump Agenda, Part 12: Flaws in CBO Studies Can Limit Policy Debates and Attorney Actions
This is Part 12 in an ongoing series regarding changes in health care that may take place—and actual changes that do take place—with the Trump administration. The likely implementation issues to be encountered for both potential and actual changes are described, based on detailed methods of analysis. The emphasis is on what these shifts mean …
Mitchell & Mitchell on Health Care and the trump Agenda, Part 11: A Pivot Point in Health Policy
This is part 11 in an ongoing series regarding changes in health care that may take place—and actual changes that do take place—with the Trump administration. The likely implementation issues to be encountered for both potential and actual changes are described, based on detailed methods of analysis. The emphasis is on what these shifts mean …
